SKI Market

A+| A| A-|

Indian Indices

Sensex

75,381.62 -633.66
( -0.83%)

Global Indices

Nasdaq

49,723.13 92.96
(0.19%)

Dow Jones

7,432.82 12.89
(0.17%)

Hang Seng

62,457.26 -256.39
(-0.41%)

Nikkei 225

10,269.73 36.66
(0.36%)

Forex

USD-INR

94.41 0.04
(0.04%)

EUR-INR

111.23 0.30
(0.27%)

GBP-INR

128.63 0.31
(0.24%)

JPY-INR

0.60 0.00
(-0.10%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Marksans Pharma consolidated net profit rises 1.58% in the September 2025 quarter

Nov 14,2025

Net profit of Marksans Pharma rose 1.58% to Rs 98.25 crore in the quarter ended September 2025 as against Rs 96.72 crore during the previous quarter ended September 2024. Sales rose 12.23% to Rs 720.41 crore in the quarter ended September 2025 as against Rs 641.92 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	720.41	641.92	12
OPM %	20.06	22.87	-
PBDT	160.25	144.11	11
PBT	133.33	124.60	7
NP	98.25	96.72	2

75,381.62 -633.66 ( -0.83%)

49,723.13 92.96 (0.19%)

7,432.82 12.89 (0.17%)

62,457.26 -256.39 (-0.41%)

10,269.73 36.66 (0.36%)

94.41 0.04 (0.04%)

111.23 0.30 (0.27%)

128.63 0.31 (0.24%)

0.60 0.00 (-0.10%)